Surface functionalized amorphous nanosilica and microsilica with nanopores as promising tools in biomedicine.
Cellular interactions with engineered nanoparticles (NPs) are dependent on many properties, inherent to the nanoparticle (viz. size, shape, surface characteristics, degradation, agglomeration/dispersal, and charge, etc.). Modification of the surface reactivity via surface functionalization of the nanoparticles to be targeted seems to be important. Utilization of different surface functionalization methods of nanoparticles is an emerging field of basic and applied nanotechnology. It is well known that many disease-causing organisms induce host lipids and if deprived, their growth is inhibited in vivo. Amorphous nanosilica (ANS) and amorphous microsilica with nanopores (AMS) were prepared by a combination of wet chemistry and high-energy ball milling. Lipophilic moieties were attached to both ANS and AMS via chemical surface functionalization method. Lipophilic ANS and AMS were found to inhibit the growth of Bombyx mori nuclear polyhedrosis virus (BmNPV) and chicken malarial parasites via absorption of silkworm hemolymph and chicken serum lipids/lipoproteins, respectively, in vivo. Therefore, intelligent surface functionalization of NP is an important concept, and its application in curing chicken malaria and BmNPV is presented here. Surface functionalization method reported in this paper might serve as a valuable technology for treating many diseases where pathogens induce host lipid.
Rahman
Ayesha
A
Biological Sciences Division, Indian Statistical Institute, 203 B. T. Road, Calcutta, India. ayesha.rahman.l@gmail.com
Seth
Dipankar
D
Mukhopadhyaya
Sunit K
SK
Brahmachary
Ratan L
RL
Ulrichs
Christian
C
Goswami
Arunava
A
D000818:Animals; D020811:Biomedical Technology / Q000379:methods*; D012831:Bombyx / Q000187:drug effects / Q000254:growth & development / Q000502:physiology; D002645:Chickens; D002784:Cholesterol / Q000097:blood; D004195:Disease Models, Animal; D007814:Larva / Q000502:physiology; D008288:Malaria / Q000097:blood / Q000473:pathology; D055616:Microtechnology / Q000379:methods; D053758:Nanoparticles / Q000627:therapeutic use; D036103:Nanotechnology / Q000379:methods; D009929:Organ Size; D012822:Silicon Dioxide / Q000737:chemistry*; D013499:Surface Properties
D012822:Silicon Dioxide; D002784:Cholesterol
Eur J Med Res. 1998 Apr 8;3(4):211-5
9533930
J Biol Chem. 2001 Aug 3;276(31):29319-29
11352913
Commun Agric Appl Biol Sci. 2006;71(2 Pt A):171-8
17390789
Bull Hist Med. 2005 Summer;79(2):261-94
15965289
Nat Immunol. 2005 Sep;6(9):946-53
16086017
J Stored Prod Res. 2001 Apr;37(2):153-164
11124378
J Biol Chem. 1994 Dec 30;269(52):33159-63
7806546
Nat Rev Immunol. 2003 Jul;3(7):557-68
12876558
Lipids Health Dis. 2005 May 09;4:10
15882457
EMBO J. 2000 Jul 17;19(14):3556-64
10899110
Naturwissenschaften. 2007 Jan;94(1):25-33
16953417
Expert Rev Anticancer Ther. 2007 Jun;7(6):833-7
17555393
Mini Rev Med Chem. 2008 Feb;8(2):175-83
18289101
Expert Opin Drug Deliv. 2007 Mar;4(2):119-29
17335410
Insect Biochem Mol Biol. 1998 Dec;28(12):927-34
9887509
Biosci Biotechnol Biochem. 2007 Jan;71(1):200-5
17213661
Curr Opin Immunol. 1995 Feb;7(1):4-10
7772280
Immunol Lett. 1998 Jun;62(2):59-66
9698099
Langmuir. 2007 Feb 13;23(4):2158-68
17279708
Nature. 2007 Dec 13;450(7172):1091-5
18046333
Parasitol Res. 2002 Dec;88(12):1040-3
12444452
Trans R Soc Trop Med Hyg. 1990 Nov-Dec;84(6):792-4
2096509
Nat Protoc. 2008;3(2):314-20
18274533
Indian J Cancer. 2004 Jan-Mar;41(1):47
15105580